521985-24-0 Usage
General Description
1-Methyl-1H-pyrrolo[2,3-b]pyridin-3-yl-3-boronic acid is a chemical compound that falls under the category of boronic acids and boronic esters. The molecular structure of this compound contains the pyrrolopyridine ring, a versatile scaffold present in numerous pharmaceuticals and natural products. It is often used as an intermediate in the synthesis of various chemical compounds due to its strong ability to interact with proteins or enzymes via the boronic acid group, which can form stable covalent bonds. It also exhibits unique physiochemical properties, useful in medicinal chemistry for the development of novel therapeutic substances. Further information regarding its specific usage and safety measures needs to be referenced from its material safety data sheet provided by the producer or distributor.
Check Digit Verification of cas no
The CAS Registry Mumber 521985-24-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,2,1,9,8 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 521985-24:
(8*5)+(7*2)+(6*1)+(5*9)+(4*8)+(3*5)+(2*2)+(1*4)=160
160 % 10 = 0
So 521985-24-0 is a valid CAS Registry Number.
521985-24-0Relevant articles and documents
AMIDE DERIVATIVES AND DRUGS
-
Page 20, (2010/02/08)
The present invention provides an amide derivative represented by the following formula [1]: wherein n represents 0 or 1; X represents CR4 or N; Y represents CR6 or N; Z represents CR7 or N; R1 and R2 may be the same or different and each represents hydrogen, optionally substituted alkyl, acyl, optionally substituted aryl, or an optionally substituted aromatic heterocyclic group; R4, R5, R6 and R7 may be the same or different and each represents hydrogen, halogen, hydroxy, amino, alkyl, haloalkyl, alkoxy, monoalkylamino, dialkylamino, arylalkyl, cyano, or nitro; and R3 represents optionally substituted alkylamino, optionally substituted arylamino, or optionally substituted cyclic amino, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising them as an active ingredient. The compound of the present invention is useful as a TGF-β inhibitor.
